First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma – A real-world experience from Israel

OBJECTIVE: Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide. It is usually treated surgically, with very high cure rates. However, in 3%-7% of cases, cSCC metastasizes to lymph nodes or distant organs. Many of the affected patients are elderly wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Averbuch, Itamar, Salman, Saeed, Shtamper, Noa, Doweck, Ilana, Popovtzer, Aron, Markel, Gal, Hendler, Daniel, Finkel, Inbar, Moore, Assaf, Fenig, Eyal, Taha, Tarek, Mhameed, Kamel, Kurman, Noga, Billan, Salem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924127/
https://www.ncbi.nlm.nih.gov/pubmed/36793605
http://dx.doi.org/10.3389/fonc.2023.1117804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924127/
https://www.ncbi.nlm.nih.gov/pubmed/36793605
http://dx.doi.org/10.3389/fonc.2023.1117804

Ejemplares similares